Abstract
AbstractA widespread strategy to increase the transport of therapeutic peptides across cellular membranes has been to attach lipid moieties to the peptide backbone (lipidation) to enhance their intrinsic membrane interaction. Effortsin vitroandin vivoinvestigating the correlation between lipidation characteristics and peptide membrane translocation efficiency have traditionally relied on end-point read-out assays and trial-and-error-based optimization strategies. Consequently, the molecular details of how therapeutic peptide lipidation affects it’s membrane permeation and translocation mechanisms remain unresolved. Here we employed salmon calcitonin as a model therapeutic peptide and synthesized nine double lipidated analogs with varying lipid chain lengths. We used single giant unilamellar vesicle (GUV) calcein influx time-lapse fluorescence microscopy to determine how tuning the lipidation length can lead to an All-or-None GUV filling mechanism, indicative of a peptide mediated pore formation. Finally, we used a GUVs-containing-inner-GUVs assay to demonstrate that only peptide analogs capable of inducing pore formation show efficient membrane translocation. Our data provided the first mechanistic details on how therapeutic peptide lipidation affects their membrane perturbation mechanism and demonstrated that fine-tuning lipidation parameters could induce an intrinsic pore-forming capability. These insights and the microscopy based workflow introduced for investigating structure-function relations could be pivotal for optimizing future peptide design strategies.Graphical AbstractHighlights- Lipidating the therapeutic peptide salmon calcitonin alters its biophysical characteristics, including oligomer size, hydrophobicity and membrane activity.- Fluorescent microscopy of single GUVs enables the determination of peptide mediated reporter dye influx behavior as either graded or All-or-None, which is coupled to either smaller membrane perturbations or peptide pore formation.- Modulating the number of hydrocarbons constituting the lipidation moieties determines the membrane permeation mechanism.- By increasing the lipid chain length lipidated of salmon calcitonin goes from displaying smaller membrane perturbations to a peptide pore formation mechanism.- Effective membrane translocation of lipidated salmon calcitonin requires a peptide mediated pore forming mechanism.
Publisher
Cold Spring Harbor Laboratory
Reference61 articles.
1. Non-invasive delivery strategies for biologics;Nat. Rev. Drug Discov,2018
2. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches;Adv. Drug Deliv. Rev,2020
3. Materials for oral delivery of proteins and peptides;Nat. Rev. Mater,2019
4. Advances in oral peptide therapeutics;Nat. Rev. Drug Discov,2019
5. Formulation strategies to improve the efficacy of intestinal permeation enhancers;Adv. Drug Deliv. Rev,2021